{"id":"NCT01128153","sponsor":"AstraZeneca","briefTitle":"Saxagliptin Triple Oral Therapy","officialTitle":"A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study to Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin and Sulfonylurea in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Combination of Metformin and Sulfonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2011-06","completion":"2011-06","firstPosted":"2010-05-21","resultsPosted":"2012-08-03","lastUpdate":"2012-08-10"},"enrollment":257,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Saxagliptin","otherNames":["Onglyza"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Saxagliptin 5 mg once daily","type":"EXPERIMENTAL"},{"label":"Placebo once daily","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the addition of saxagliptin to a patient's combination treatment of metformin and sulfonylurea for a 24 week period will provide better control of the patient's type 2 diabetes and will be well tolerated.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 24, Last Observation Carried Forward (LOCF)","timeFrame":"From Baseline to Week 24 weeks","effectByArm":[{"arm":"Arm 1 - SAXAGLIPTIN","deltaMin":-0.74,"sd":null},{"arm":"Arm 2 - PLACEBO","deltaMin":-0.08,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":33,"countries":["Australia","Canada","India","South Korea","Thailand","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":129},"commonTop":["Nasopharyngitis","Diarrhoea","Upper Respiratory Tract Infection","Urinary Tract Infection","Dyslipidaemia"]}}